A detailed history of Bay Harbor Wealth Management, LLC transactions in Kaleido Biosciences, Inc. stock. As of the latest transaction made, Bay Harbor Wealth Management, LLC holds 2,300 shares of KLDO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,300
Holding current value
$0
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$0.0 - $0.0 $0 - $0
2,300 New
2,300 $0
Q1 2024

Apr 22, 2024

BUY
$0.0 - $0.0 $0 - $0
2,300 New
2,300 $0

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0

About Kaleido Biosciences, Inc.


  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Bay Harbor Wealth Management, LLC Portfolio

Follow Bay Harbor Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.